We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$24B
AUM Growth
+$1.05B
Cap. Flow
-$221M
Cap. Flow %
-0.92%
Top 10 Hldgs %
13.73%
Holding
1,494
New
103
Increased
612
Reduced
406
Closed
115

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$114M
2
AET
Aetna Inc
AET
+$96.3M
3
TRV icon
Travelers Companies
TRV
+$94.5M
4
CHK
Chesapeake Energy Corporation
CHK
+$89M
5
AEE icon
Ameren
AEE
+$69.4M

Top Sells

Rank Stock Value
1
DB icon
Deutsche Bank
DB
+$247M
2
VZ icon
Verizon
VZ
+$186M
3
MDT icon
Medtronic
MDT
+$150M
4
LO
LORILLARD INC COM STK
LO
+$126M
5
JCI icon
Johnson Controls International
JCI
+$104M

Sector Composition

Rank Sector Weight
1 Healthcare 15.44%
2 Technology 14.68%
3 Financials 12.75%
4 Industrials 11.1%
5 Energy 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EMN icon
376
Eastman Chemical
EMN
$7.53B
$10.8M 0.05%
123,900
-17,400
-12% -$1.51M
RCI icon
377
Rogers Communications
RCI
$19.4B
$10.8M 0.04%
267,606
-2,900
-1% -$117K
SEE
378
DELISTED
Sealed Air
SEE
$10.7M 0.04%
313,900
+25,800
+9% +$853K
TRN icon
379
Trinity Industries
TRN
$2.24B
$10.7M 0.04%
338,360
– –
QGENF
380
DELISTED
QIAGEN NV
QGENF
$10.6M 0.04%
435,247
+17,134
+4% +$419K
DD icon
381
DuPont de Nemours
DD
$17.3B
$10.4M 0.04%
80,130
+20,216
+34% +$2.58M
CSX icon
382
CSX Corp
CSX
$90.1B
$10.4M 0.04%
1,015,830
-3,492,720
-77% -$34M
AUY
383
DELISTED
Yamana Gold, Inc.
AUY
$10.4M 0.04%
1,259,077
+1,033,714
+459% +$8.11M
JOYY
384
JOYY Inc
JOYY
$3.78B
$10.4M 0.04%
+137,403
New +$8.96M
SLM icon
385
SLM Corp
SLM
$4.92B
$10.2M 0.04%
1,230,850
+1,151,107
+1,444% +$10.1M
NVDQ
386
DELISTED
Novadaq Technologies Inc.
NVDQ
$10.2M 0.04%
618,000
+45,000
+8% +$741K
TGT icon
387
Target
TGT
$70.1B
$10.2M 0.04%
175,378
+11,726
+7% +$690K
MET icon
388
MetLife
MET
$62.4B
$10.2M 0.04%
205,152
+47,729
+30% +$2.23M
PPL
389
PPL Corp
PPL
$25B
$10.1M 0.04%
306,031
+9,562
+3% +$301K
LH icon
390
Labcorp
LH
$26.3B
$10.1M 0.04%
114,404
+8,811
+8% +$763K
TFC icon
391
Truist Financial
TFC
$61.6B
$10M 0.04%
254,800
-1,000
-0.4% -$38.3K
IBN icon
392
ICICI Bank
IBN
$102B
$9.92M 0.04%
1,093,725
– –
OMC icon
393
Omnicom Group
OMC
$21.9B
$9.92M 0.04%
139,237
+80,562
+137% +$5.61M
CACI icon
394
CACI
CACI
$14.1B
$9.84M 0.04%
140,165
-22,580
-14% -$1.6M
BX icon
395
Blackstone
BX
$95.1B
$9.79M 0.04%
298,476
-56,663
-16% -$1.75M
HRI icon
396
Herc Holdings
HRI
$4.65B
$9.68M 0.04%
115,110
-33,233
-22% -$2.8M
CMP icon
397
Compass Minerals
CMP
$1B
$9.64M 0.04%
+100,690
New +$9.08M
EWG icon
398
iShares MSCI Germany ETF
EWG
$1.68B
$9.62M 0.04%
307,507
-7,471
-2% -$236K
SCZ icon
399
iShares MSCI EAFE Small-Cap ETF
SCZ
$12.8B
$9.61M 0.04%
181,660
-490
-0.3% -$25.6K
GM icon
400
General Motors
GM
$74.9B
$9.52M 0.04%
262,339
-514,414
-66% -$17.9M
14 15
16
17 18

Similar funds

VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
FA
Forefront Analytics West Conshohocken, Pennsylvania $92M AUM 25.18% 1-Year Est. Return
PBCM
Point Break Capital Management Miami, Florida $91.7M AUM
CCAM
Crystal Cove Asset Management Newport Beach, California $91.7M AUM
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
AWP
Atlas Wealth Partners Wyomissing, Pennsylvania $91.6M AUM 9.52% 1-Year Est. Return
HI
Hyundai Investments Yeongdeungopo-Gu, Seoul, South Korea $92.3M AUM 0.12% 1-Year Est. Return
DCA
DB&C Advisors Holland, Michigan $92.4M AUM

Axa's Q2 2014 Portfolio in Review

As of Q2 2014, Axa held 1,494 positions worth $24B, up 4.6% from $23B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q2 2014 filing shows 103 new, 612 increased, 406 reduced and 115 closed positions. Its largest new stake was Boston Scientific: 4,394,250 shares worth $56.1M. The largest sale was Deutsche Bank, an estimated $247M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q2 2014 buy was Boston Scientific: 4,394,250 shares worth $56.1M.
  • Axa added most to Gilead Sciences in Q2 2014, an estimated $114M increase.
  • Axa's biggest Q2 2014 reduction was Deutsche Bank, cutting an estimated $247M.
  • Axa fully exited OMNICARE INC in Q2 2014, selling an estimated $20.4M.
  • Axa's ten largest holdings make up 14% of its $24B portfolio in Q2 2014.
  • Axa opened 103 new positions and closed 115 in Q2 2014.
  • Axa's portfolio value rose 4.6% quarter-over-quarter to $24B.

Based on Axa's 13F filing for Q2 2014, filed 13 Aug 2014.